| This week's sponsor is TD2. | | | |
Featured Story | | | Tuesday, September 26, 2017 The philosophy of Fierce 15 is a simple one: We want to see the best science combined with the brightest teams, and we want to see the promise that they hold in their hands has a genuine chance of being the Next Big Thing. This year’s crop comprises some of the best-funded startups we’ve seen and speaks volumes about the rude health of early-stage biomedical research. |
|
|
| This week's sponsor is FierceBiotech. | | | FierceBiotech Executive Summit- London
Join FierceBiotech for our third annual Executive Summit in London. We'll gather the experts together to discuss innovation around R&D in the UK and look ahead to what's in store for 2018 with leaders in the field discussing trends in the industry. |
Top Stories Tuesday, September 26, 2017 With the backing of a young, media-savvy entrepreneur and a $2.6 billion valuation, all seemed bright for a company hoping to reverse the fortunes of Alzheimer’s R&D. But what matters in biotech is data, and Axovant is now just another company that tried and failed in a space that has caused nothing but big disappointments in R&D. Tuesday, September 26, 2017 Genocea Biosciences has hung a "for sale" sign on its phase 3-ready herpes drug and committed to axing 40% of its staff. The moves refocus Genocea as an early-phase player in the hot neoantigen cancer vaccine sector but got short shrift from investors, who drove its stock down more than 50%. Monday, September 25, 2017 RBM shouldn’t be a point of concern, but rather a point of validation of what matters. It’s, above all, an opportunity to practice mindfulness in collecting clinical trial data within the site-and patient-centric environment. Tuesday, September 26, 2017 London-based CAR-T player Autolus has raised $80 million in a third-round financing that it says will fund proof-of-concept testing for three programs. Tuesday, September 26, 2017 Khosla Ventures and Seventure Partners have driven Eligo Bioscience to a $20 million (€17 million) series A. The round equips Eligo to move its lead CRISPR-enabled, bacteria-killing candidate toward the clinic in a rare disease indication. Monday, September 25, 2017 Each year, our crop of Fierce 15 honorees includes an increasing number of nontraditional device players. In a nod to the rise of new medical technologies, FierceMedTech is selecting our first medtech Fierce 15—and we need your help. We are looking for medtech trailblazers working on new ways to approach the diagnosis and treatment of disease. | This week's sponsor is CMed. | | | |
Resources Sponsored by: Veeva Systems The 2017 Unified Clinical Operations Survey finds that 99% of respondents report the need to unify their clinical applications, including CTMS, EDC, eTMF, and study start-up. Presented By: Catalent Learn how Catalent Biologics is paving the way for flexible biologics development and manufacturing through advanced technologies and fully integrated multi-product facility. Presented By: Catalent Download the eBook to get articles from various Elsevier journals highlighting developments in ADC technology. Presented By: Catalent Learn how cell development and process scale-up can be optimized for antibodies requiring additional processing. Sponsored by: Ashfield Healthcare Join this webinar to learn how to design, deliver, and measure a successful patient support program. Presented by Nareda Mills, Ashfield's SVP of Patient Services in the US, you’ll discover how to improve adherence and improve patient outcomes using 5 key methods. Presented By: PRA Health Sciences Children participating in pediatric clinical trials are included in the contraceptive requirements applied to women of child-bearing potential, creating significant challenges for sponsors, parents, investigators and study staff. Sponsored By: RTI Health Solutions In this webinar, we will introduce the rapidly-evolving within-subject clinical trial (WSCT) methods for early phase evidence generation that require fewer people, less time, and usually less funding than traditional early phase methods. 2nd Strategic Partnerships for Drug Repurposing October 26-27, 2017 | Boston, MA Compliance Certificate and Training for Life Sciences Professionals October 9 -12, 2017 | Newark, NJ CBI’s MedComm 2017 Conference October 26-27, 2017 | San Francisco, CA FierceBiotech 2nd Drug Development Forum September 25-27, 2017 | Boston, MA FierceBiotech Executive Summit- London October 2, 2017 | London 11th Digital Pharma East October 3-6, 2017 | Philadelphia, PA Life Sciences Innovation Awards | Don't Miss This Opportunity Application Deadline: Friday, October 20 at midnight EST Drug Development Boot Camp® 2017 November 15-16, 2017 | Boston, MA | 